Cargando…
DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease
Lead, a known neurotoxicant, has previously received attention in Parkinson’s disease (PD) research, but epidemiologic studies have been limited in sample size and findings are equivocal. We generated two methylation-based biomarkers for cumulative tibia and patella bone-measured lead exposure in 15...
Autores principales: | Paul, Kimberly C., Horvath, Steve, Del Rosario, Irish, Bronstein, Jeff M., Ritz, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983295/ https://www.ncbi.nlm.nih.gov/pubmed/33752746 http://dx.doi.org/10.1186/s13148-021-01051-3 |
Ejemplares similares
-
Accelerated hematopoietic mitotic aging measured by DNA methylation, blood cell lineage, and Parkinson’s disease
por: Paul, Kimberly C, et al.
Publicado: (2021) -
Parkinson’s disease is associated with DNA methylation levels in human blood and saliva
por: Chuang, Yu-Hsuan, et al.
Publicado: (2017) -
Blood DNA Methylation Biomarkers of Cumulative Lead Exposure in Adults
por: Colicino, Elena, et al.
Publicado: (2019) -
Immune system disruptions implicated in whole blood epigenome-wide association study of depression among Parkinson's disease patients
por: Paul, Kimberly C., et al.
Publicado: (2022) -
Ambient Pyrethroid Pesticide Exposures in Adult Life and Depression in Older Residents of California’s Central Valley
por: Furlong, Melissa A., et al.
Publicado: (2020)